Aucta Pharmaceuticals

Aucta Pharmaceuticals is a company focused on the development of improved new drugs. Based on existing proven drug molecules, the company explores innovative treatment methods through new dosage forms, new drug delivery regimens, and new indications to create higher-quality products that meet clinical and market demands. The majority of the company’s products are submitted to the FDA in the United States via the 505(b)(2) pathway, while in China they are filed as Class II new drugs with the Chinese CFDA. In terms of therapeutic focus, the company emphasizes central nervous system (CNS) disorders, topical dermatological formulations, and pediatric medications. Aucta is committed to patient-centered innovation, continuously introducing products to the market based on creative improvements of known molecules. Aucta Pharmaceuticals has research and development centers in New Jersey, USA, and Shanghai, China.